Normalization of fluorescence-based quantitative real-time PCR (qPCR) data varies across quantitative gene expression studies, despite its integral role in accurate data quantification and interpretation. Identification of suitable reference genes plays an essential role in accurate qPCR normalization, as it ensures that uncorrected gene expression data reflect normalized data. The reference residual normalization (RRN) method presented here is a modified approach to conventional 2
INTRODUCTION
Normalization method plays an essential role in the accurate quantification and interpretation of gene expression data. However, fluorescence-based quantitative real-time PCR (qPCR) normalization methodology is not standardized across gene expression studies, despite attempts to do so (e.g., Minimum Information for Publication of Quantitative Real-Time PCR Experiments). 1, 2 To address this issue, we developed a mathematically explicit and statistically rigorous approach to qPCR normalization that enhances 2
Ϫ⌬⌬Ct methodology 3, 4 and Minimum Information for Quantitative Experiments (MIQE) compliance. The reference residual normalization (RRN) method presented here improves mathematical transparency through the use of sample-specific reference residuals (RR i ), generated from the mean C t of one or more reference gene(s), to normalize corresponding C t values (C ti ) of one or more target gene(s). RRN also incorporates statistical support (i.e., P value) for putative reference genes by determining the effect of treatment (e.g., ANOVA) and minimum permitted resolution (e.g., equivalence threshold test). Through mathematical transparency and statistical rigor, RRN promotes compliance with MIQE to provide increased confidence in qPCR normalization and interpretation.
Data used in examples (see Tables 1-4) were recently generated as part of a larger, yet unpublished, gene expression study on developing zebrafish by R. Edmunds and J. Incardona. Zebrafish embryos were obtained from adults maintained at the Northwest Fisheries Science Center (NOAA; Seattle, WA, USA) using conventional zebrafish animal care protocols. 5 cDNA was synthesized from a normalized quantity (1 g) of total RNA. All C t values were determined using a fixed threshold fluorescence of 0.1 across all qPCR runs. Gene-specific efficiencies (E) were established off the slopes of standard curves generated from serial dilution of cDNA and pooled equally across all samples (nϭ14). 6 Expression data were collected using Power SYBR Green chemistry (Applied Biosystems, Life Technologies, Carlsbad, CA, USA) on a 7700 Prism (Applied Biosystems, Life Technologies), running standard cycling conditions. 6 Reference genes (technical and biological) can be used to correct gene expression data for technical variance (e.g., reverse transcription and/or loading differences) as well as biological variance (e.g., cell number and/or RNA population changes), respectively. Normalization to a biological reference gene can be done as a preliminary step before conventional ⌬⌬C t normalization (i.e., ⌬⌬⌬C t ). This type of normalization is most appropriate when unaffected technical reference genes cannot be identified, suggesting substantial sample-to-sample variation in the starting mRNA population (e.g., samples collected across developmental time or tissue type). 7 Given the variability in selection and use of biological reference genes across laboratories and experimental paradigms, explicit examples of ⌬⌬⌬C t normalization are not provided herein.
Regardless of intended application, expression of biological and/or technical reference genes across treatments should be accompanied by statistical support. The expectation is that biological reference gene expression is affected by treatment, developmental stage, or tissue type, whereas technical reference gene expression is unaffected. Statistical tests of biological and technical reference gene expression are of critical importance, as normalization to affected 6 and unaffected 8 reference genes results in the most biologically accurate conclusions, respectively. More specifically, foldchange values are calculated using 2 ⌬Ct or E ⌬Ct (100% or reaction-specific E, respectively) and log 2 -transformed to restore normal distribution before statistical testing of treatment effect (Table 1 and Fig. 1, Step 1) . Conventional methods of means comparison (e.g., Student's t-test for control vs. one treatment or one-way ANOVA with Dunnett's post-hoc for control vs. two or more treatments) can be used to determine whether reference genes are considered affected (PϽ0.05) or unaffected (PϾ0.10) by treatment ( Fig. 1, Step 1.5.1).
Given the importance of identifying technical reference genes that are unaffected by treatment for accurate normalization, increasing ␣ (e.g., ␣ϭ0.10) and consequently decreasing ␤ are recommended for avoidance of Type II error. Moreover, technical reference genes identified as unaffected by treatment should be subjected to an equivalence test to determine statistically the smallest difference in log 2 -transformed fold change (e.g., 0.56) required to obtain significant equivalence (PϽ0.05; Table 1 ). This threshold establishes the minimum change in target gene expression (e.g., 1.5-fold; Table 1 ) necessary to be considered as a biologically significant response to treatment (i.e., regardless of statistical significance). Note that if preliminary biological reference gene normalization (i.e., ⌬⌬⌬C t ) is appropriate, then biological RR i should be applied to C ti values of technical reference gene(s) before expression calculations and statistical tests are conducted (Fig. 1) . equivalence testing demonstrates that a difference up to 1.325 (2.5-fold) is significantly equivalent (PϽ0.05) between both treatments. Consideration must also be given to the difference in standard error of the mean (SE) associated with differences in endogenous transcript abundance of technical reference genes (i.e., low-vs. high-abundance transcripts). The C t values for low-abundance (e.g., tissue-specific loci within a mixed-tissue RNA population) technical reference genes generally exhibit larger standard error (Ϯ0.2 to Ϯ1 SE), which translates into statistical stability (PϾ0.10) and results in larger technical RR i values than do high-abundance (e.g., ubiquitous) technical reference genes. High-abundance technical reference genes can appear affected by treatment (PϽ0.10), as a result of an inherently small error (Ϯ0.03 to Ϯ0.10 SE); however, subsequent equivalence testing may establish that a practical equivalence threshold is acceptably low (e.g., Յ1.5-fold). Conversely, if biological and/or technical reference genes exhibit large variation (Ն1 SE) and thus, appear unaffected by treatment (e.g., PϾ0.10), subsequent equivalence testing may establish that the practical equivalence threshold is unacceptably high (e.g., greater than two-fold). Therefore, gene expression studies designed to quantify multiple target genes that exhibit a tissue-specific-to-ubiquitous range of endogenous abundance are encouraged to normalize using RR i generated from the geometric mean of two or more technical reference genes that exhibit a similar tissue-specific-toubiquitous range of endogenous abundance. If preliminary normalization to a biological reference gene is appropriate, the use of a high-abundance transcript is recommended, as ⌬⌬⌬C t influences C ti values of technical reference and target genes.
Following the identification of suitable technical reference gene(s), RR i can be generated from the overall mean of control and treatment C t values (Fig. 1, Step 2 ). More specifically, RR i captures the inherent variance of technical reference genes by subtracting the overall mean C t from the C t of each control and treatment replicate, respectively (see Table 2 for example of RR i generation). Generated RR i
Step 1: Determine suitability of reference gene(s) Step-by-step instructions for applying RRN to qPCR data. RRN can be applied to target gene(s) using biological and technical reference genes together (i.e., ⌬⌬⌬C t ) or technical reference gene(s) alone (i.e., ⌬⌬C t ). values are positive or negative, depending on how the C t value of a given replicate differs from the overall mean C t value. If normalization to a biological reference gene is appropriate, then generation and application of biological RR i to corresponding technical reference and target C ti values should be completed as a preliminary step (Fig. 1, Step 2.1).
Technical RR i can also be generated from multiple reference genes by calculating the mean C t for each individual sample (e.g., geometric mean) 9,10 before calculating the overall mean of control and treatment C t values (Fig. 1 , Steps 2.1.1 and 2.1.2). Note that RR i can be generated from the median instead of the mean if nonparametric statistics are considered needed and used to establish suitability of technical reference gene(s).
Once RR i have been generated, qPCR expression data can be normalized using the RRN method (Fig. 1, Step 3, and Table 3 ). The application of RR i to target C ti values corrects for the inherent variance in technical reference gene expression. Table 3 provides a comprehensive example of the mathematically explicit method used by RRN for target gene normalization to affected and unaffected technical reference genes. Normalization of Target 1 and Target 2 to the unaffected technical reference gene (Reference 1) results in ϳ88% and ϳ87% retention of uncorrected expression, whereas normalization to the affected technical reference gene (Reference 2) results in only ϳ55% and ϳ53% retention of uncorrected expression, respectively ( Table 3 ). Note that the influence of biological reference gene normalization can be larger than technical normalization alone, as it normalizes for biological variation in both technical reference and target gene expression patterns (e.g., differing number of cells in tissue samples with identical weights). 7 The downstream influence of this alteration on data interpretation depends on the magnitude of target gene expression, with assays targeting subtle changes in expression (e.g., less than five-fold; Table 3 , Target 2) being more sensitive to a reduction in expression after normalization than assays targeting robust changes (e.g., greater than five-fold; Table 3 , Target 1). Accordingly, consideration must also be given to the direction of expression for both technical reference and target genes as their interactions are additive. 1 More specifically, concurrent normalization (i.e., up-regulated target gene normalized to up-regulated technical reference) results in a reductive influence on target gene expression, whereas opposing normalization (i.e., up-regulated target gene normalized to down-regulated technical reference) results in an additive influence.
To avoid incorrect downstream conclusions, as a result of such influence of technical reference gene normalization on target gene expression pattern(s), statistical testing of uncorrected and corrected log 2 -transformed fold-change values is recommended (Fig. 1, Steps 1 uncorrected expression, ϳ50%; and loss of significance in Target 2 expression after Treatments 1 and 2, Pϭ0.0547 and 0.1012 respectively). Table 4 presents parallel statistical analyses on uncorrected and corrected values to demonstrate the importance of normalizing to technical reference gene(s) that are unaffected by treatment, especially for quantitative molecular studies targeting genes that exhibit subtle (less than five-fold) changes in response to treatment (e.g., tissue-specific mRNAs, non-coding RNAs, or micro RNAs). [11] [12] [13] In summary, RRN improves transparency and confidence regarding qPCR analysis and interpretation. This method uses explicit mathematics and rigorous statistics to increase confidence in identification of suitable reference gene(s), which is essential for accurate normalization of target genes. Through enhanced MIQE compliance and transparency, the use of RRN improves the biological accuracy of quantitative gene expression studies.
